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Introduction
The HCV genome is highly heterogeneous, owing to the
high mutation rate of RNA viruses. There are seven HCV
genotypes, with numerous subtypes and viral quasispecies.
The prevalence and distribution of HCV genotypes varies
globally, and strains show highly variable sensitivity to
available therapeutics. Thus, genetic and epidemiological
studies of hepatitis C infection are significant, especially
within high-risk cohorts where viral evolution can be
rapid and unpredictable.
Materials and methods
We collected blood samples from intravenous drug users
(IVDU) and performed ELISAs to determine HCV positiv-
ity. RNA extraction, reverse transcription PCR and DNA
sequencing were performed in the Core-E1 and NS5B
regions. Strain subtyping was performed using the Oxford
HCV subtyping tool v2.0. Phylogenetic analysis was done
by aligning and comparing the sequences of both regions
to reference strains from the Los Alamos database, using
the neighbor-joining method and the Kimura two-para-
meter distance estimation approach in MEGA v4. The
reliability of the phylogenetic clustering was evaluated
using bootstrap analysis with 1,000 replicates, and boot-
strap values above 70 were considered sufficient for sub-
type assignment.
Results
21 out of 64 research subjects (32.8%) were positive for
HCV, a percentage much lower than the global average
(60%) amongst IVDUs. All individuals were infected
with genotypes 3a (62%), or 1b (32%), and no unique
recombinants were identified. Interestingly, none of the
subjects were infected with the 1a strain, a genotype
that is highly associated with intravenous drug use, and
is also prevalent in the general Cypriot population. In
contrast, 38% of the subjects were infected with strain
1b, which is fairly uncommon amongst IVDUs. Finally,
we observed three small clusters within the IVDU
group, suggesting possibles h a r i n go fi n j e c t i n g
equipment.
Conclusions
HCV infection within IVDUs in Cyprus is polyphyletic,
with high genetic heterogeneity, as seen by the limited
clustering within this group. Absence of large clusters
also suggests that sharing of injecting equipment is
uncommon. HCV prevalence amongst IVDUs is signifi-
cantly lower than the global average, and only circulation
of subtypes 1b and 3a is observed, in contrast to the gen-
eral population where all genotypes are present.
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